Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

vTv Therapeutics' Shares open 80% Higher on Phase 2 Type 1 Diabetes Trial Data

Shares of vTv Therapeutics traded 50% higher after the company reported positive results from Part 2 of the Phase 2 Simplici-T1 Study of TTP399 used in the treatment of patients with type 1 diabetes. Clinical-stage pharmaceutical company focused on treating ...
Streetwise Reports | February 11, 2020 |

Standard Lithium Successfully Commissioned Demonstration Plant Despite COVID-19

The Critical Investor takes a look at the current dynamics of the lithium market, and speaks with the Standard Lithium's CEO about the firm's latest news. LiSTR demonstration plant at Lanxess project site After Standard Lithium Ltd. (SLL:TSX.V; ST...
Streetwise Reports | June 15, 2020 |

Buzz on the Bullboards: The Summer’s Most Talked About Sectors

The summer trading season is well underway as we celebrate a holiday here in Canada and this weekend in the US. Even on days that the markets were closed, the Bullboards on Stockhouse are wide open and busy with lively discussions on some of the biggest (and smallest) sto...
Stockhouse Editorial | June 30, 2021 |

INmune Bio Targeting Cancer, Alzheimer's and NASH Simultaneously

We are initiating coverage on INmune Bio Inc. (INMB:NASDAQ) . According to the company, INmune is "Reprogramming the Innate Immune System for the Treatment of Diseases." On the surface, this sounds like a fairly standard biotech tagline, but there's a more here than me...
Streetwise Reports | December 5, 2019 |

Star Navigation: Bridging the gap between flight experience and flight safety in real-time

Star Navigation bridges the gap between flight experience and flight safety in real time. When it comes to the aerospace industry, the Ontario-based leading-edge technology company offers both hardware and software solutions. The company’s real-time ca...
Simon Druker | November 2, 2022 |

New technology to screen for security threats

Liberty Defense Holdings ( TSXV:SCAN ) ( OTCQB:LDDFF ) has spent USD$30 million over the last two years developing a next generation threat detection solution for the aviation and the urban security market. The company recently announced sales and is making progress on a ...
Brieanna McCutcheon | May 15, 2023 |

Biotech 'Thinking Several Steps Ahead with Optimizing IVR Quality Control

The company's latest science, presented at a recent conference, is discussed in a ROTH Capital Partners report. In a July 31 research note, ROTH Capital Partners analyst Yasmeen Rahimi reported that Daré Bioscience Inc. (DARE:NASDAQ) presented two posters o...
Streetwise Reports | August 6, 2019 |

Deadly Mine Collapse in the DRC to Have Repercussions

The potential effects of the event on the copper market and the project's major joint venture partner are outlined in a BMO Capital Markets report. In a June 27 research note, BMO Capital Markets analyst Ed Sterck wrote that the fatal mine collapse from ...
Streetwise Reports | July 2, 2019 |

Coverage Initiated on Immunotherapies Developer with 'Catalyst Rich 2020'

The key business and investment points are presented in a ROTH Capital Partners report. In a Dec. 18 research note, analyst Jonathan Aschoff reported that ROTH Capital Partners initiated coverage on Inovio Pharmaceuticals Inc. (INO:NASDAQ) with a Buy rating and a "c...
Streetwise Reports | December 27, 2019 |

Buzz on the Bullboards: Feeling the tech selloff?

It has been a turbulent week on Bay Street and Wall Street. Canada’s commodity-heavy main stock index tumbled this week, weighed down by a near 5% drop in crude prices on demand concerns, while bullion prices slipped to a four-week low further hurting...
Stockhouse Editorial | April 27, 2022 |
1 2 3 4 5 6 7 8 9 10 ...